|
Stock Information
MOLOGEN AG, Berlin |
ISIN: |
DE0006637200 |
| Securities Identification Number: |
663720 |
| SE code: |
MGN |
| Stock exchange: |
Frankfurt stock exchange |
| Market segment: |
Prime Standard (Regulated Market)
|
| Subscribed Capital: |
EUR 11,158,348 |
| Number of shares: |
10,658,348 |
|
|
NEWS
|
June 22, 2010
MOLOGEN AG receives approval for clinical study with cell-based gene therapy against renal cancer
 press release
ad-hoc announcement
|
|
June 22, 2010
MOLOGEN AG starts phase 2 clinical study with DNA-based cancer medicine MGN1703 against colorectal cancer
more
|
NEWSLETTER |
| To subscribe to our Newsletter please
click here |
|
|
STOCK
INFORMATION
ANNOUNCEMENTS